Shanu Modi
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 103
- HER2/EGFR in Cancer Research 85
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 7
-
- Advanced Breast Cancer Therapies 14
- Brain Metastases and Treatment 14
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Sarat Chandarlapaty (23 shared papers)Joshua Z. Drago (11 shared papers)Komal L. Jhaveri (16 shared papers)Ian E. Krop (24 shared papers)Clifford A. Hudis (26 shared papers)Gabriela Chiosis (7 shared papers)Larry Norton (24 shared papers)Tony Taldone (3 shared papers)
- Journals
- Annals of Oncology (26 papers)Journal of Clinical Oncology (12 papers)Clinical Breast Cancer (9 papers)Clinical Cancer Research (9 papers)ESMO Open (8 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Shanu Modi
157 papers receiving 14.5k citations
Shanu Modi's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 6.2k
- Cancer Research 2.6k
- Radiology, Nuclear Medicine and Imaging 1.9k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 2.5k
Countries citing papers authored by Shanu Modi
This map shows the geographic impact of Shanu Modi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanu Modi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanu Modi more than expected).
Fields of papers citing papers by Shanu Modi
This network shows the impact of papers produced by Shanu Modi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanu Modi. The network helps show where Shanu Modi may publish in the future.
Co-authors
The 25 scholars most cited alongside Shanu Modi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Hit paper breakdown → | 2022 | 1933 |
| 2 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer Hit paper breakdown → | 2019 | 1606 |
| 3 | Unlocking the potential of antibody–drug conjugates for cancer therapy Hit paper breakdown → | 2021 | 917 |
| 4 | The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers Hit paper breakdown → | 2018 | 776 |
| 5 | Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study Hit paper breakdown → | 2020 | 633 |
| 6 | 2010 | 492 | |
| 7 | A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab Hit paper breakdown → | 2021 | 473 |
| 8 | 2011 | 409 | |
| 9 | 2011 | 364 | |
| 10 | Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies Hit paper breakdown → | 2021 | 324 |
| 11 | 2019 | 309 | |
| 12 | 2012 | 306 | |
| 13 | 2014 | 287 | |
| 14 | 2007 | 286 | |
| 15 | 2016 | 239 | |
| 16 | ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer Hit paper breakdown → | 2023 | 236 |
| 17 | 2019 | 196 | |
| 18 | 2012 | 193 | |
| 19 | Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies Hit paper breakdown → | 2022 | 190 |
| 20 | 2021 | 184 |
About Shanu Modi
Shanu Modi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 163 papers that have together received 14.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (85 papers), Heat shock proteins research (19 papers), Breast Cancer Treatment Studies (19 papers), Advanced Breast Cancer Therapies (14 papers), Brain Metastases and Treatment (14 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (6.2k citations), Cancer Research (2.6k citations), Radiology, Nuclear Medicine and Imaging (1.9k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Molecular Biology (2.5k citations). Shanu Modi has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Sarat Chandarlapaty, Joshua Z. Drago, Komal L. Jhaveri, Ian E. Krop, Clifford A. Hudis, Gabriela Chiosis, Larry Norton, Tony Taldone, Hiroji Iwata and Shunji Takahashi. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Breast Cancer, Clinical Cancer Research and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.